Injury guide

Roundup and Blood Cancer: Care and Claims

Get care for symptoms and keep your diagnosis and product records. A study or claim does not decide what caused your illness.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202616 sources

This may apply to you if

  • Review the exact product and exposure history.
  • Review the cancer diagnosis and date in the medical record.
  • Review earlier cases, releases and proposed class-program rules.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

International Agency for Research on Cancer · World Health Organization · Cancer agency issuing the March 2015 evaluation

Finding: The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.

IARC glyphosate evaluation, March 20, 2015 (opens in a new tab) · Mar 20, 2015 · Checked Oct 3, 2026

The evidence and its limits

National Cancer Institute and Agricultural Health Study collaborators · Journal of the National Cancer Institute · 2018

Glyphosate Use and Cancer Incidence in the Agricultural Health Study

Design:
Cohort
Participants:
54,251 licensed pesticide applicators; 44,932 reported glyphosate use
Finding:
The cohort did not find an overall link between glyphosate use and non-Hodgkin lymphoma.
Main limitation
Exposure was self-reported in a specific work population. This observational result cannot decide what caused one person’s cancer.

Read the source: Glyphosate Use and Cancer Incidence in the Agricultural Health Study (opens in a new tab) · Checked Oct 3, 2026

International Agency for Research on Cancer, World Health Organization · 2015

IARC Monographs Volume 112 glyphosate evaluation

Design:
Agency review
Participants:
No single sample; review of human, animal and laboratory evidence
Finding:
The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.
Main limitation
Limited human evidence means other explanations for a link could not be ruled out. A hazard classification does not prove a personal cause.

Read the source: IARC Monographs Volume 112 glyphosate evaluation (opens in a new tab) · Checked Oct 3, 2026

The short answer

What is non-Hodgkin lymphoma?
It is cancer in the lymph system, which helps the body fight infection. There are different types and growth rates. [16]
What signs should I see a doctor about?
Swollen glands, fever, night sweats, fatigue or weight loss can be signs. They can also have other causes, so ask a doctor. [16]
How is it diagnosed and treated?
Doctors use your history, an exam and tests to diagnose the disease. Treatment choices depend on the type, stage and your health. [16]
What does the research say?
IARC found a possible link with this cancer in human studies, with limits. A large worker study found no overall link with this cancer or its types. [2]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

When it fits this case

  • Review the exact product and exposure history.
  • Review the cancer diagnosis and date in the medical record.
  • Review earlier cases, releases and proposed class-program rules.

What is non-Hodgkin lymphoma?

It is cancer in the lymph system, which helps the body fight infection. There are different types and growth rates.

The National Cancer Institute’s guide explains that some forms grow slowly and others grow quickly. Ask your care team for the full diagnosis and subtype in writing. A product-use history is a separate question from identifying and treating the cancer.

What signs should I see a doctor about?

Swollen glands, fever, night sweats, fatigue or weight loss can be signs. They can also have other causes, so ask a doctor.

NCI advises checking these symptoms with a clinician rather than diagnosing yourself. Tell the care team when changes began and what else you are experiencing. Seek medical advice about symptoms without waiting to decide whether a legal claim or a settlement notice applies.

How is it diagnosed and treated?

Doctors use your history, an exam and tests to diagnose the disease. Treatment choices depend on the type, stage and your health.

NCI describes tests that can include blood work and a lymph-node biopsy, where tissue is examined for cancer. Ask which tests support your diagnosis and what your care plan means. Do not choose or delay treatment based on a possible lawsuit outcome.

What does the research say?

IARC found a possible link with this cancer in human studies, with limits. A large worker study found no overall link with this cancer or its types.

The worker study followed licensed pesticide users in Iowa and North Carolina; it was not a trial or a study of every home use. IARC’s hazard review and EPA’s assessment differ. EPA says a revised health review is expected in late 2026; these sources do not prove one person’s cause.

Who may have a claim to check?

Ask a lawyer to check your diagnosis, product use and law. A diagnosis alone does not mean a claim or program will pay.

The Supreme Court’s June 25, 2026 ruling bars Durnell’s cancer-label warning claim under federal pesticide law; it does not declare every possible claim ended. The proposed King agreement has its own membership and payment rules. Ask which path and current court documents fit your facts.

What records should I gather?

Keep diagnosis and care records, product details and dates of use. Ask about missing medical or billing copies.

Covered providers generally allow access to these records, with exceptions and possible copying charges. Bring any settlement notice too. Ask a lawyer about filing limits, the effect of a release and written fee and expense terms; do not assume a notice gives every patient the same options.

Scientific evidence for this case

Roundup lawsuit: who may qualify and what happens next · Mutation Research / Reviews in Mutation Research · 2019Meta-analysis

Exposure to Glyphosate-Based Herbicides and Risk for Non-Hodgkin Lymphoma: A Meta-Analysis

41% increased risk of NHL among highest-exposed individuals (OR = 1.41, 95% CI: 1.13-1.75)

Roundup lawsuit: who may qualify and what happens next · IARC Monographs on the Evaluation of Carcinogenic Risks to Humans · 2015Meta-analysis

IARC Monograph Volume 112: Glyphosate Evaluation

Classified glyphosate as Group 2A — "probably carcinogenic to humans"

Roundup lawsuit: who may qualify and what happens next · Journal of the National Cancer Institute · 2018Cohort

Glyphosate Use and Cancer Incidence in the Agricultural Health Study

No statistically significant overall association between glyphosate and NHL in the full cohort

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. Supreme Court: Monsanto v. Durnell, June 25, 2026; checked 2026-10-03.Supreme Court: Monsanto v. Durnell, June 25, 2026 · court
  2. IARC glyphosate evaluation, March 20, 2015; checked 2026-10-03.IARC glyphosate evaluation, March 20, 2015
  3. Andreotti and colleagues: Agricultural Health Study; checked 2026-10-03.Andreotti and colleagues: Agricultural Health Study · study
  4. EPA: glyphosate review; checked 2026-10-03.EPA: glyphosate review · regulator
  5. King v. Monsanto preliminary approval order, March 4, 2026; checked 2026-10-03.King v. Monsanto preliminary approval order, March 4, 2026 · court
  6. King fairness hearing order, August 6, 2026; checked 2026-10-03.King fairness hearing order, August 6, 2026 · court
  7. Court-authorized Weed Killer Class notice and FAQs; checked 2026-10-03.Court-authorized Weed Killer Class notice and FAQs · court
  8. HHS: Your Medical Records; checked 2026-10-03.HHS: Your Medical Records · regulator
  9. Federal courts: civil cases; checked 2026-10-03.Federal courts: civil cases · court
  10. ABA: fees paid from a successful claim; checked 2026-10-03.ABA: fees paid from a successful claim
  11. SDNY: filing time limits; checked 2026-10-03.SDNY: filing time limits · court
  12. ABA Model Rule 1.5: fees; checked 2026-10-03.ABA Model Rule 1.5: fees
  13. JPML Pending MDL Dockets by Actions Pending, Oct. 1, 2026JPML Pending MDL Dockets by Actions Pending, Oct. 1, 2026 · court
  14. JPML Pending MDL Dockets by Actions Pending, July 1, 2026JPML Pending MDL Dockets by Actions Pending, July 1, 2026 · court
  15. JPML Pending MDL Dockets by Actions Pending, Sept. 1, 2026JPML Pending MDL Dockets by Actions Pending, Sept. 1, 2026 · court
  16. National Cancer Institute: adult non-Hodgkin lymphoma patient guide

Checked against 13 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026